Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

of tumor necrosis factor-a from macrophages.
Enhancement and suppression
are dose-dependently regulated by prostaglandin
E2 and cyclic nucleotides.
J. Immunol. 141: 2388.
218 Attiga, F. A., P. M. Fernandez,
A. T. Weeraratna, M. J. Manyak and
S. R. Patierno. 2000. Inhibitors of
prostaglandin synthesis inhibit human
prostate tumor cell invasiveness and reduce
the release of matrix metalloproteinases.
Cancer Res. 60: 4629.
219 Snyderman, C. H., I. Klapan, M. Milanovich,
D. S. Heo, R. Wagner,
D. Schwartz, J. T. Johnson and
T. L. Whiteside. 1994. Comparison of
in vivo and in vitro prostaglandin E2 production
by squamous cell carcinoma of
the head and neck. Otolaryngol. Head.
Neck Surg. 111: 189.
220 Cohen, L. A. and R. A. Karmali. 1984.
Endogenous prostaglandin production
by established cultures of neoplastic rat
mammary epithelial cells. In Vitro 20:
119.
221 Eisengart, C. A., J. R. Mestre,
H. A. Naama, P. J. Mackrell, D. E. Rivadeneira,
E. M. Murphy, P. P. Stapleton
and J. M. Daly. 2000. Prostaglandins
regulate melanoma-induced
cytokine production in macrophages.
Cell Immunol. 204: 143.
222 Young, M. R., E. Wheeler and
M. Newby. 1986. Macrophage-mediated
suppression of natural killer cell activity
in mice bearing Lewis lung carcinoma.
J. Natl Cancer Inst. 76: 745.
223 Milanovich, M. R., C. H. Snyderman,
R. Wagner and J. T. Johnson. 1995.
Prognostic significance of prostaglandin
E2 production by mononuclear cells
and tumor cells in squamous cell carcinomas
of the head and neck. Laryngoscope
105: 61.
224 Sumitani, K., R. Kamijo, T. Toyoshima,
Y. Nakanishi, K. Takizawa, M. Hatori
and M. Nagumo. 2001. Specific inhibition
of cyclooxygenase-2 results in inhibition
of proliferation of oral cancer cell
lines via suppression of prostaglandin
E 2 production. J. Oral Pathol. Med. 30:
41.
225 Arvind, P., E. D. Papavassiliou,
G. J. Tsioulias, L. Qiao, C. I. Lovelace,
References
B. Duceman and B. Rigas. 1995. Prostaglandin
E2 down-regulates the expression
of HLA-DR antigen in human colon
adenocarcinoma cell lines. Biochemistry
34: 5604.
226 Ben-Efraim, S. and I. L. Bonta. 1994.
Modulation of antitumour activity of
macrophages by regulation of eicosanoids
and cytokine production. Int. J.
Immunopharmacol. 16: 397.
227 Shinomiya, S., H. Naraba, A. Ueno,
I. Utsunomiya, T. Maruyama, S. Ohuchida,
F. Ushikubi, K. Yuki, S. Narumiya,Y.
Sugimoto, A. Ichikawa and
S. Oh-ishi. 2001. Regulation of TNFa
and interleukin-10 production by prostaglandins
I(2) and E(2): studies with
prostaglandin receptor-deficient mice
and prostaglandin E-receptor subtypeselective
synthetic agonists. Biochem.
Pharmacol. 61: 1153.
228 Strassmann, G.,V. Patil-Koota,
F. Finkelman, M. Fong and T. Kambayashi.
1994. Evidence for the involvement
of interleukin 10 in the differential
deactivation of murine peritoneal
macrophages by prostaglandin E2.
J. Exp. Med. 180: 2365.
229 Phipps, R. P., S. H. Stein and R. L. Roper.
1991. A new view of prostaglandin
E regulation of the immune response.
Immunol. Today 12: 349.
230 Roper, R. L. and R. P. Phipps. 1994.
Prostaglandin E2 regulation of the immune
response. Adv. Prostaglandin
Thromboxane Leukot. Res. 22: 101.
231 Plescia, O. J., K. Grinwich and
A. M. Plescia. 1976. Subversive activity
of syngeneic tumor cells as an escape
mechanism from immune surveillance
and the role of prostaglandins. Ann. NY
Acad. Sci. 276: 455.
232 Young, M. R. and S. Henderson.
1982. Enhancement in immunity of tumor
bearing mice by immunization
against prostaglandin E2. Immunol.
Commun. 11: 345.
233 Parhar, R. S. and P. K. Lala. 1988.
Prostaglandin E2-mediated inactivation
of various killer lineage cells by tumorbearing
host macrophages. J. Leuk. Biol.
44: 474.
234 Snijdewint, F. G., P. Kalinski,
E. A. Wierenga, J. D. Bos and
149